{"entity":{"id":"nct06864624","kind":"trial","name":"Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC","aka":["WU-KONG20"],"tldr":"A phase 2 trial of sunvozertinib in lung cancer, run by Tang-Du Hospital, now recruiting.","summary":"Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC is a phase 2, interventional study registered as NCT06864624 by Tang-Du Hospital, with a registry enrolment figure of 27 participants, started 2025-02-18 and due to reach its primary completion in 2026-12. Interventions recorded: Sunvozertinib. Conditions listed: NSCLC. Primary outcome: Objective response rate (ORR) of neoadjuvant therapy. Lung eligibility wording from the registry: \"Non-small cell lung cancer confirmed by histopathology or cytology, clinical stage II, IIIA or IIIB (N2) assessed by the investigator according to AJCC 8th edition\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT06864624","url":"https://clinicaltrials.gov/study/NCT06864624"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["egfr-mutant-nsclc","resectable-nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["sunvozertinib"],"companies":["dizal"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06864624","phase":"2","setting":"Sunvozertinib as Neoadjuvant and Adjuvant Therapy in Stage II-IIIB Non-small-cell Lung Cancer Patients With EGFR Exon 20 Insertion Mutation: a Single-arm, Phase 2 Study (WU-KONG20)","sponsor":"Tang-Du Hospital","enrolled":27,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06864624/","neighbours":{"cancer":[{"id":"egfr-mutant-nsclc","kind":"cancer","name":"EGFR-mutated non-small-cell lung cancer","route":"/cancers/egfr-mutant-nsclc/"},{"id":"resectable-nsclc","kind":"cancer","name":"Resectable stage I to III non-small-cell lung cancer","route":"/cancers/resectable-nsclc/"}],"drug":[{"id":"sunvozertinib","kind":"drug","name":"Sunvozertinib","route":"/drugs/sunvozertinib/"}],"company":[{"id":"dizal","kind":"company","name":"Dizal Pharmaceutical","route":"/companies/dizal/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}